Core Viewpoint - Zhongjian Technology has submitted its prospectus to the Hong Kong Stock Exchange, aiming to raise funds primarily for expanding its robotics business and increasing production capacity domestically and internationally to capitalize on the artificial intelligence robotics market [2]. Group 1: Company Overview - Zhongjian Technology, established in 1997, specializes in outdoor power equipment, including a full range of gasoline and lithium battery products such as chainsaws and lawn mowers [3]. - The company has achieved significant overseas sales, with products sold in over 50 countries and regions, and only 5% of its revenue coming from mainland China as of mid-2025 [5]. Group 2: Financial Performance - In 2024, Zhongjian Technology's total revenue increased from 512 million yuan in 2022 to 971 million yuan, with a compound annual growth rate (CAGR) of 37.6%, while net profit rose from 27.4 million yuan to 61.5 million yuan, with a CAGR of 49.8% [5]. - However, in 2025, the company experienced a slowdown in revenue growth, with a 4.45% year-on-year increase in the first three quarters, and a significant 43.6% drop in net profit [6][7]. Group 3: Market Challenges - The company faced challenges due to global tariff disruptions, leading to a decline in sales of its core products, particularly chainsaws, which saw a drop from 225,500 units to 152,200 units year-on-year [8]. - The overall export environment is tough, with a decline in export amounts for electric tools and lawn mowers to North America [8]. Group 4: Strategic Initiatives - To mitigate international trade friction, Zhongjian Technology has established a production base in Thailand to optimize its supply chain [8]. - The company is diversifying into the robotics sector, having developed capabilities in smart lawn mowers and quadruped robots, with initial orders for its Lingrui P1 quadruped robot targeting enterprise and government markets [9][11]. Group 5: Future Outlook - The global smart lawn mower market is projected to grow from $1.2 billion in 2024 to $9.9 billion by 2029, with a CAGR of 51.8%, indicating a promising opportunity for Zhongjian Technology [9]. - The company has partnered with major tech firms like OpenAI and NVIDIA to enhance its robotics capabilities, although it faces short-term profit pressures and increased R&D expenditures [11].

Group 1: Stock Buybacks in Hong Kong - Hong Kong companies have repurchased shares worth approximately 1544.15 billion HKD, with 247 companies buying back a total of 67.69 million shares as of November 25 [1] - In November alone, 90 companies repurchased shares totaling around 83.33 million HKD, with a concentration in sectors such as finance, information technology, consumer goods, healthcare, and energy [1] - The trend of stock buybacks is expected to continue into 2025, with leading companies demonstrating confidence in their valuations and contributing to market stability [1] Group 2: New Listings on Hong Kong Stock Exchange - Newguodu (SZ300130) has submitted its prospectus to the Hong Kong Stock Exchange, aiming to expand its financing channels and enhance its competitiveness in the global payment sector [2] - Olin Bio (SH688319) has also filed for a listing on the Hong Kong Stock Exchange, focusing on innovative vaccines, particularly in the areas of "super bacteria vaccines" and "adult vaccines" [3] - Zhongjian Technology (SZ002779) has applied for a listing on the Hong Kong Stock Exchange, seeking to leverage the capital market to expand its business in outdoor power equipment [4] Group 3: Hong Kong Stock Market Performance - The Hang Seng Index closed at 25928.08, with a slight increase of 0.13% on November 26 [5] - The Hang Seng Tech Index reached 5618.36, reflecting a gain of 0.11% [5] - The National Enterprises Index stood at 9162.37, showing a modest rise of 0.04% [5]

Focus 1: Jianlong Micro-Nano (688357) - The company has terminated the planning of a major asset restructuring, which was intended to acquire at least 51% of Shanghai Hanxing Energy Technology Co., Ltd. through cash payment for equity [1] Focus 2: Industrial Fulian - The company has adjusted the maximum repurchase price for its shares from 19.36 yuan per share to 75.00 yuan per share, reflecting confidence in its future development and market conditions [2] Focus 3: *ST Dongtong - The company received a prior notice from the Shenzhen Stock Exchange regarding the proposed termination of its stock listing [3] Focus 4: Fundraising & Restructuring - Aolaide plans to raise up to 299.71 million yuan through a simplified procedure for issuing shares to specific targets, with proceeds allocated for OLED display core material production and working capital [4] - Maigemi has received approval from the Shenzhen Stock Exchange for its application to issue shares to specific targets, meeting all necessary conditions [4] - Su Yan Jingshen has also received approval for its share issuance application, pending final registration with the China Securities Regulatory Commission [4] Focus 5: Important Matters - Baiao Chemical's major shareholders are transferring a total of 10% of the company's shares to Liu Hongjun, resulting in him holding 10% of the total share capital post-transfer [5][6] - Zhejiang Pharmaceutical is planning to spin off its subsidiary for a listing on the Hong Kong Stock Exchange, which will not affect its control over the subsidiary [6] - Huafeng Aluminum is acquiring 100% of Shanghai Huafeng Puen Polyurethane Co., Ltd. for 100.06 million yuan, which will enhance its operational efficiency and market competitiveness [7] Focus 6: New Investments - Fuda Co. is establishing a wholly-owned subsidiary with an investment of 30 million yuan to enhance its forging business and related manufacturing capabilities [8] - Jianghai Co. is forming a joint venture to establish an innovation research institute with a registered capital of 50 million yuan, focusing on strategic technology research [9][10] Focus 7: Capital Market Activities - Zhongshan Bank has issued 60 billion yuan of subordinated debt with a fixed interest rate of 2.16% for a term of 10 years [17] - China Iron and Steel Group plans to increase its stake in China Iron and Steel Co. by investing between 65 million and 130 million yuan over the next six months [18]

Core Viewpoint - Zhongjian Technology has submitted its IPO application to the Hong Kong Stock Exchange, aiming to raise funds for the industrialization of quadruped robots, upgrades of smart lawn mowers, and expansion of production bases in Thailand and China [2] Financial Performance - The company's net profit growth has significantly slowed, with a year-on-year increase of less than 2% in the first half of this year [2] - The net cash flow from operating activities dropped sharply from 102 million yuan in 2022 to 5.997 million yuan in 2024, a decrease of 94.12% [2][9] - Revenue for the reporting periods was 512 million yuan, 667 million yuan, 971 million yuan, and 503 million yuan, with corresponding net profits of 27.41 million yuan, 48.12 million yuan, 61.51 million yuan, and 45.68 million yuan [6] Sales and Market Presence - Overseas sales revenue increased to 95% in the first half of this year, with significant contributions from Europe and North America [3] - The company ranks among the top ten outdoor power equipment manufacturers in China, according to global revenue estimates for 2024 [2] Product Development and R&D - Zhongjian Technology is transitioning from traditional outdoor power equipment to advanced smart robots, with R&D expenses increasing by 127.3% from 17.2 million yuan in the first half of 2024 to 39 million yuan in the first half of this year [8] - The company has received recognition as a "specialized and innovative" small giant enterprise and as a high-tech enterprise in Zhejiang Province [2] Operational Challenges - The company has faced a decline in contract liabilities, which fell from approximately 29.9 million yuan in 2022 to 6.6 million yuan in 2024, a reduction of 46% [8] - The asset-liability ratio increased from 0.3% in 2022 to 14% by mid-2025, attributed to new bank loans and increased lease liabilities [9] Corporate Governance - The company's shares are highly concentrated, with the chairman and his family holding a combined 46.01% of the shares [11] - There have been compliance issues regarding social insurance and housing fund contributions for employees, attributed to local government interpretations of laws [11]

Group 1: Storage Market Dynamics - The storage spot market is experiencing strong demand, leading to continued price increases for finished products, despite high prices [1] - Customers with low inventory levels are gradually accepting new pricing agreements, providing manufacturers with confidence to raise prices [1] - The significant price increases are affecting retail markets, with online and offline retailers raising prices for memory modules and SSDs, potentially reducing consumer purchasing willingness [1] Group 2: DRAM Industry Forecast - According to TrendForce, the DRAM industry revenue is expected to grow by 30.9% quarter-on-quarter in Q3 2025, reaching $41.4 billion due to rising contract prices and increased shipment volumes [1] - The fourth quarter is anticipated to see a significant increase in contract prices, with conventional DRAM prices expected to rise by 45%-50% [1] - The overall contract prices for conventional DRAM and HBM combined are projected to increase by 50%-55% [1] Group 3: Medical Device Market Growth - The Chinese medical device market is projected to reach ¥1.22 trillion by 2025, with over 33,000 production enterprises expected by the end of 2024, marking a 27.8% increase from the end of the 13th Five-Year Plan [2] - The industry is transitioning from "catching up" to "running alongside and leading," supporting the "Healthy China" strategy [2] Group 4: Flu Season Impact on Pharmaceuticals - The flu season has started early in China, with a 237% increase in sales of Oseltamivir over the past week, and a 180% increase for Maviral [2] - The peak of the flu season is expected between mid-December and early January [2] Group 5: Cinema Industry Growth - As of October 2023, China has added 233 cinemas and 1,588 screens, totaling 15,438 operating cinemas and 92,556 screens nationwide [3] - County-level cinemas account for 21.06% of the total, while town cinemas make up 18.01% [3] Group 6: Innovations in Medical Technology - Novo Nordisk's Kyinsu, the world's first weekly insulin and GLP-1 receptor agonist combination, has been approved in the EU for adults with type 2 diabetes [3] - This innovation represents a significant advancement in diabetes treatment options [3] Group 7: Corporate Developments - Allianz Partners plans to lay off 1,500 to 1,800 employees over the next 12-18 months, primarily in call center roles due to automation [5] - Novartis announced plans to cut up to 550 jobs in Switzerland by the end of 2027 as part of production adjustments [5]

Group 1 - Aolide plans to raise no more than 300 million yuan through a simplified procedure for issuing shares to specific targets, with net proceeds allocated to the production base project for OLED display core materials and to supplement working capital [1] - Wanbang's subsidiary has obtained a 10-year exclusive agency for sildenafil oral suspension, which is suitable for patients with swallowing difficulties [2] - Titan Technology and its affiliate plan to jointly invest in increasing capital for its subsidiary, Micro Detection, raising its registered capital from 10 million yuan to 50 million yuan [3] Group 2 - Jindike will not issue new batches of quadrivalent influenza virus split vaccine this year, having produced approximately 1.56 million doses [4] - Aladdin intends to purchase 35% equity of Youke for 61.25 million yuan, funded by its own or raised capital [5] - Gujia Home's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] Group 3 - Honghe Technology's application for a private placement of A-shares has been approved by the China Securities Regulatory Commission [9] - Guangdian Yuntong has won contracts totaling 308 million yuan for the construction of an artificial intelligence application pilot base [10] - Shanghai Mechanical plans to repurchase B-shares worth no more than 278 million yuan [11] Group 4 - Weiling Co. is planning a change of control, with shares representing 7.76% of the total being transferred [14] - Jiugang Hongxing intends to invest 200 million yuan to establish a wholly-owned subsidiary focusing on high-quality special steel materials [16] - Zhongjian Technology has submitted an application for H-share listing [17] Group 5 - Sainuo Medical has received registration approval for its coronary product in Pakistan [18] - Huafeng Aluminum plans to acquire 100% equity of Huafeng Puen for 100 million yuan [20] - Fuda Co. intends to establish a wholly-owned subsidiary with an investment of 30 million yuan [22] Group 6 - Su Yan Jingshen's application for a private placement of shares has been approved by the Shanghai Stock Exchange [24] - Zhongchuang Co. has set the inquiry transfer price at 25.75 yuan per share [25] - Jinpu Garden has had a lawsuit involving 26.557 million yuan accepted by the court [29] Group 7 - ICBC has approved the appointment of Zhao Guid as vice president [30] - Betta Pharmaceuticals has had its drug registration application for ensartinib accepted [32] - Times New Materials plans to invest 6 million euros to establish a wholly-owned subsidiary in Serbia [34] Group 8 - China State Construction has appointed Chen Yong as vice president [36] - Dayang Electric plans to invest 10 million yuan to establish an industrial fund [38] - Advanced Digital has appointed Liu Zhigang as deputy general manager [39] Group 9 - Tianqi Co. plans to transfer 7% equity of Youqi Intelligent for 130 million yuan [40] - Xinguo has submitted an application for H-share issuance and listing [42] - Jinhongshun's shareholder has terminated a share reduction plan [43] Group 10 - Wanrun Co.'s actual controller plans to increase shareholding between 365 million yuan and 730 million yuan [44] - Suzhou High-tech plans to sell 47% equity of its medical device subsidiary for 604 million yuan [45] - Huayou Cobalt's subsidiary has signed a product supply agreement with Yiwei Lithium Energy for approximately 127,800 tons of materials [47] Group 11 - China Communications has won 10 important projects totaling approximately 2.539 billion yuan [49] - Nopushin plans to raise no more than 1.45 billion yuan through a private placement [50] - Yun Aluminum plans to acquire minority stakes in three subsidiaries for a total of 2.267 billion yuan [51] Group 12 - Xiamen Tungsten plans to establish a 500 million yuan merger fund with multiple parties [52] - Aotewei has signed a contract worth approximately 700 million yuan [54] - Hemai Co.'s shareholders plan to reduce their holdings by no more than 3% [56]

中坚科技11月26日公告，公司已于2025年11月25日向香港联合交易所有限公司递交了发行境外上市股份 （H股）并在香港联交所主板挂牌上市的申请，并于同日在香港联交所网站刊登了本次发行并上市的申 请材料。 ...

中坚科技（002779）(002779.SZ)发布公告，公司已于2025年11月25日向香港联合交易所有限公司(简 称"香港联交所")递交了发行境外上市股份(H股)并在香港联交所主板挂牌上市的申请，并于同日在香港 联交所网站刊登了本次发行并上市的申请材料。该申请材料为公司按照香港证券及期货事务监察委员会 (简称"香港证监会")及香港联交所的要求编制和刊发，为草拟版本，其所载资料可能会适时作出更新及 修订，投资者不应根据其中的资料作出任何投资决定。 ...

证券代码：002779 证券简称：中坚科技 公告编号：2025-049 关于向香港联交所递交H股发行并上市申请 需要特别予以说明的是，本公告仅为境内投资者及时了解本次发行并上市的 相关信息而作出。本公告以及公司刊登于香港联交所网站的申请资料均不构成也 并刊发申请资料的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 不得视作对任何个人或实体收购、购买或认购公司本次发行并上市的 H 股的要 约或要约邀请。公司本次发行并上市尚需取得中国证券监督管理委员会、香港证 监会和香港联交所等相关政府机关、监管机构、证券交易所的批准、核准或备案， 该事项仍存在不确定性。公司将根据该事项的进展情况依法及时履行信息披露义 务，敬请广大投资者注意投资风险。 中文：https://www1.hkexnews.hk/app/sehk/2025/107890/documents/sehk25112 501561_c.pdf 英文：https://www1.hkexnews.hk/app/sehk/2025/107890/documents/sehk25112 501562.pdf 浙 ...

智通财经APP讯，中坚科技(002779.SZ)发布公告，公司已于2025年11月25日向香港联合交易所有限公司 (简称"香港联交所")递交了发行境外上市股份(H股)并在香港联交所主板挂牌上市的申请，并于同日在香 港联交所网站刊登了本次发行并上市的申请材料。该申请材料为公司按照香港证券及期货事务监察委员 会(简称"香港证监会")及香港联交所的要求编制和刊发，为草拟版本，其所载资料可能会适时作出更新 及修订，投资者不应根据其中的资料作出任何投资决定。 ...